A woman who has been taking a weight-loss injection for nearly a decade is urging Americans to stop taking these drugs solely for weight loss. Danielle Payton, 33, is thought to be one of the longest-serving patients on a GLP-1 agonist, which was first approved in 2010. These drugs are at the center of concerns about long-term safety risks, already being linked to and .
Load More
Load More